Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans.
Eberlein, T J
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans. [electronic resource] - Cancer immunology, immunotherapy : CII 1989 - 145-50 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0340-7004
10.1007/BF01669422 doi
Adjuvants, Immunologic--pharmacology
Cytotoxicity, Immunologic
Humans
Interleukin-2--pharmacokinetics
Killer Cells, Lymphokine-Activated--immunology
Lymphocytes--immunology
Neoplasms--therapy
Phenotype
Recombinant Proteins--pharmacokinetics
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans. [electronic resource] - Cancer immunology, immunotherapy : CII 1989 - 145-50 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0340-7004
10.1007/BF01669422 doi
Adjuvants, Immunologic--pharmacology
Cytotoxicity, Immunologic
Humans
Interleukin-2--pharmacokinetics
Killer Cells, Lymphokine-Activated--immunology
Lymphocytes--immunology
Neoplasms--therapy
Phenotype
Recombinant Proteins--pharmacokinetics